Market Place
Sourcing Support
Enforcement Report - Week of April 22, 2026
22 Apr 2026 //
FDA
Enforcement Report - Week of April 15, 2026
15 Apr 2026 //
FDA
Enforcement Report - Week of January 28, 2026
28 Jan 2026 //
FDA
Enforcement Report - Week of January 21, 2026
21 Jan 2026 //
FDA
Enforcement Report - Week of December 17, 2025
17 Dec 2025 //
FDA
Enforcement Report - Week of December 10, 2025
10 Dec 2025 //
FDA
Enforcement Report - Week of August 27, 2025
27 Aug 2025 //
FDA
Enforcement Report - Week of July 30, 2025
30 Jul 2025 //
FDA
Enforcement Report - Week of November 20, 2024
20 Nov 2024 //
FDA
FDA Issues form 483 to Cipla Goa
26 Jun 2024 //
FDA
FDA Issues form 483 to Cipla Ltd.
07 Jun 2024 //
FDA
Enforcement Report - Week of May 1, 2024
01 May 2024 //
FDA
FDA Issues form 483 to Cipla
10 Apr 2024 //
FDA
Cipla Limited on Health Canada Inspection List
13 Dec 2023 //
HEALTH CANADA
Cipla Limited Receives FDA Warning Letter
21 Nov 2023 //
FDA
Enforcement Report - Week of July 19, 2023
19 Jul 2023 //
FDA
FDA Issues Form 483 to Cipla Limited
02 Mar 2023 //
FDA
Enforcement Report - Week of October 12, 2022
12 Oct 2022 //
FDA
Enforcement Report - Week of October 5, 2022
05 Oct 2022 //
FDA
FDA Isuued form 483 to Cipla Limited (8/26/2022)
22 Sep 2022 //
FDA
Enforcement Report - Week of September 14, 2022
14 Sep 2022 //
FDA
FDA Issues Form 483 to Cipla`s Manufacturing Site in India
17 Aug 2022 //
FDA
Enforcement Report - Week of July 27, 2022
27 Jul 2022 //
FDA
Cipla recalls 7,228 bottles of overactive bladder treatment drug in America
25 Jul 2021 //
ECONOMIC TIMES
Enforcement Report - Week of July 21, 2021
21 Jul 2021 //
FDA
Enforcement Report - Week of January 6, 2021
06 Jan 2021 //
FDA
Cipla Limited Unit VIII,X,Unit III on Health Canada Inspection List
18 Jul 2020 //
HEALTH CANADA
Cipla Limited on Health Canada Inspecion List
13 May 2020 //
HEALTH CANADA
Cipla Limited Receives FDA Warning Letter
18 Mar 2020 //
FDA
FDA Issues Form 483 to Cipla Limited (Goa-India)
12 Oct 2019 //
FDA
FDA Issues Form 483 to Cipla Ltd. Virgonagar Site
31 Jul 2019 //
FDA
Enforcement Report - Week of April 24, 2019
24 Apr 2019 //
FDA
Enforcement Report - Week of December 26, 2018
26 Dec 2018 //
FDA
Cipla Receives FDA Form 483
23 Oct 2018 //
FDA
Enforcement Report - Week of October 17, 2018
17 Oct 2018 //
FDA
Enforcement Report - Week of September 26, 2018
26 Sep 2018 //
FDA
Enforcement Report - Week of May 30, 2018
29 May 2018 //
FDA
FDA Issues Form 483 to Cipla Ltd
28 Mar 2018 //
FDA
Enforcement Report - Week of April 19, 2017
19 Apr 2017 //
FDA
Enforcement Report - Week of March 8, 2017
08 Mar 2017 //
FDA
Cipla Limited Initiates Class II Recall of Levalbuterol Inhalation Solution
21 May 2015 //
FDA
HC Reserves Order on Novartis-Cipla Drug Dispute
17 Dec 2014 //
